Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Denosumab for Spinal Cord Injury
Recruiting3 awardsPhase 4
West Orange, New Jersey
This trial is testing if the drug denosumab can prevent bone loss in people who have had a recent spinal cord injury. The drug is already used for other bone loss conditions but is experimental for this purpose. It works by stopping the process that breaks down bones, helping to keep them strong.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.